Swipe om te navigeren naar een ander artikel
Studies have suggested that clinicians do not feel comfortable with the interpretation of symptom severity, functional status, and quality of life (QoL). Implementation strategies of these types of measurements in clinical practice imply that consensual norms and guidelines regarding data interpretation are available. The aim of this study was to define subgroups of patients according to the levels of symptom severity using a method of interpretable clustering that uses unsupervised binary trees.
The patients were classified using a top-down hierarchical method: Clustering using Unsupervised Binary Trees (CUBT). We considered a three-group structure: “high”, “moderate”, and “low” level of symptom severity. The clustering tree was based on three stages using the 9-symptom scale scores of the EORTC QLQ-C30: a maximal tree was first developed by applying a recursive partitioning algorithm; the tree was then pruned using a criterion of minimal dissimilarity; finally, the most similar clusters were joined together. Inter-cluster comparisons were performed to test the sample partition and QoL data.
Two hundred thirty-five patients with different types of cancer were included. The three-cluster structure classified 143 patients with “low”, 46 with “moderate”, and 46 with “high” levels of symptom severity. This partition was explained by cut-off values on Fatigue and Appetite Loss scores. The three clusters consistently differentiated patients based on the clinical characteristics and QoL outcomes.
Our study suggests that CUBT is relevant to define the levels of symptom severity in cancer. This finding may have important implications for helping clinicians to interpret symptom profiles in clinical practice, to identify individuals at risk for poorer outcomes and implement targeted interventions.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Miaskowski, C., Aouizerat, B. E., Dodd, M., & Cooper, B. Conceptual issues in symptom clusters research and their implications for quality-of-life assessment in patients with cancer. Journal of the National Cancer Institute Monographs 2007:39–46. https://doi.org/10.1093/jncimonographs/lgm003.
Miaskowski, C., Cooper, B. A., Paul, S. M., Dodd, M., Lee, K., Aouizerat, B. E., et al. (2006). Subgroups of patients with cancer with different symptom experiences and quality-of-life outcomes: A cluster analysis. Oncology Nursing Forum, 33, E79–E89. https://doi.org/10.1188/06.ONF.E79-E89. CrossRefPubMed
Ferreira, K. A. S. L., Kimura, M., Teixeira, M. J., Mendoza, T. R., da Nóbrega, J. C. M., Graziani, S. R., et al. (2008). Impact of cancer-related symptom synergisms on health-related quality of life and performance status. Journal of Pain and Symptom Management, 35, 604–616. https://doi.org/10.1016/j.jpainsymman.2007.07.010. CrossRefPubMed
Gwede, C. K., Small, B. J., Munster, P. N., Andrykowski, M. A., & Jacobsen, P. B. (2008). Exploring the differential experience of breast cancer treatment-related symptoms: A cluster analytic approach. Supportive Care in Cancer, 16, 925–933. https://doi.org/10.1007/s00520-007-0364-2. CrossRefPubMed
Pud, D., Ben Ami, S., Cooper, B. A., Aouizerat, B. E., Cohen, D., Radiano, R., et al. (2008). The symptom experience of oncology outpatients has a different impact on quality-of-life outcomes. Journal of Pain and Symptom Management, 35, 162–170. https://doi.org/10.1016/j.jpainsymman.2007.03.010. CrossRefPubMed
Illi, J., Miaskowski, C., Cooper, B., Levine, J. D., Dunn, L., West, C., et al. (2012). Association between pro- and anti-inflammatory cytokine genes and a symptom cluster of pain, fatigue, sleep disturbance, and depression. Cytokine, 58, 437–447. https://doi.org/10.1016/j.cyto.2012.02.015. CrossRefPubMedPubMedCentral
Reese, J. B., Blackford, A., Sussman, J., Okuyama, T., Akechi, T., Bainbridge, D., et al. (2015). Cancer patients’ function, symptoms and supportive care needs: A latent class analysis across cultures. Quality of Life Research, 24, 135–146. https://doi.org/10.1007/s11136-014-0629-4. CrossRefPubMed
Miaskowski, C., Cooper, B. A., Melisko, M., Chen, L.-M., Mastick, J., West, C., et al. (2014). Disease and treatment characteristics do not predict symptom occurrence profiles in oncology outpatients receiving chemotherapy. Cancer, 120, 2371–2378. https://doi.org/10.1002/cncr.28699. CrossRefPubMedPubMedCentral
Miaskowski, C., Dunn, L., Ritchie, C., Paul, S. M., Cooper, B., Aouizerat, B. E., et al. (2015). Latent class analysis reveals distinct subgroups of patients based on symptom occurrence and demographic and clinical characteristics. Journal of Pain and Symptom Management, 50, 28–37. https://doi.org/10.1016/j.jpainsymman.2014.12.011. CrossRefPubMedPubMedCentral
Langford, D. J., Paul, S. M., Cooper, B., Kober, K. M., Mastick, J., Melisko, M., et al. (2016). Comparison of subgroups of breast cancer patients on pain and co-occurring symptoms following chemotherapy. Supportive Care in Cancer, 24, 605–614. https://doi.org/10.1007/s00520-015-2819-1. CrossRefPubMed
Doong, S.-H., Dhruva, A., Dunn, L. B., West, C., Paul, S. M., Cooper, B. A., et al. (2015). Associations between cytokine genes and a symptom cluster of pain, fatigue, sleep disturbance, and depression in patients prior to breast cancer surgery. Biological Research for Nursing, 17, 237–247. https://doi.org/10.1177/1099800414550394. CrossRefPubMed
Astrup, G. L., Hofsø, K., Bjordal, K., Guren, M. G., Vistad, I., Cooper, B., et al. (2017). Patient factors and quality of life outcomes differ among four subgroups of oncology patients based on symptom occurrence. Acta Oncologica, 56, 462–470. https://doi.org/10.1080/0284186X.2016.1273546. CrossRefPubMed
Dodd, M. J., Cho, M. H., Cooper, B. A., Petersen, J., Bank, K. A., Lee, K. A., et al. (2011). Identification of latent classes in patients who are receiving biotherapy based on symptom experience and its effect on functional status and quality of life. Oncology Nursing Forum, 38, 33–42. https://doi.org/10.1188/11.ONF.33-42. CrossRefPubMed
Hagenaars, J. A., & McCutcheon, A. L. (2002). Applied latent class analysis. Cambridge: Cambridge University Press. CrossRef
Michel, P., Baumstarck, K., Boyer, L., Fernandez, O., Flachenecker, P., Pelletier, J., et al. (2014). Defining quality of life levels to enhance clinical interpretation in multiple sclerosis: Application of a novel clustering method. Medical Care. https://doi.org/10.1097/MLR.0000000000000117.
Michel, P., Baumstarck, K., Auquier, P., Loundou, A., Ghattas, B., Lançon, C., et al. (2015). How to interpret multidimensional quality of life questionnaires for patients with schizophrenia? Quality of Life Research. https://doi.org/10.1007/s11136-015-0982-y.
Leplege, A., Ecosse, E., Pouchot, J., Coste, J., & Perneger, T. (2001). MOS SF36 questionnaire. Manual and guidelines for scores’ interpretation. Paris: Editions Estem.
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85, 365–376. CrossRefPubMed
Carver, C. S. (1997). You want to measure coping but your protocol’s too long: Consider the brief COPE. International Journal of Behavioral Medicine, 4, 92–100. https://doi.org/10.1207/s15327558ijbm0401_6. CrossRefPubMed
Muller, L., & Spitz, E. (2003). Multidimensional assessment of coping: Validation of the Brief COPE among French population. L’Encephale, 29, 507–518. PubMed
Baumstarck, K., Alessandrini, M., Hamidou, Z., Auquier, P., Leroy, T., & Boyer, L. (2017) Assessment of coping: A new French four-factor structure of the brief COPE inventory. Health and Quality of Life Outcomes. https://doi.org/10.1186/s12955-016-0581-9.
Halyard, M. Y., Frost, M. H., Dueck, A., & Sloan, J. A. (2006). Is the use of QOL data really any different than other medical testing? Current Problems in Cancer, 30, 261–271. https://doi.org/10.1016/j.currproblcancer.2006.08.004. CrossRefPubMed
Halyard, M. Y., Frost, M. H., & Dueck, A. (2006). Integrating QOL assessments for clinical and research purposes. Current Problems in Cancer, 30, 319–330. https://doi.org/10.1016/j.currproblcancer.2006.08.009. CrossRefPubMed
Hennig, C. (2015). Clustering strategy and method selection. ArXiv150302059 Stat 2015.
Hennig, C. (2005). A method for visual cluster validation. In: P. D. C. Weihs & P. D. W. Gaul (Eds.) Classification—The ubiquitous challenge (pp. 153–160). Berlin: Springer. https://doi.org/10.1007/3-540-28084-7_15.
Hennig, C., Meila, M., Murtagh, F., & Rocci, R. (Eds.). (2015). Handbook of cluster analysis (1st ed.). Boca Raton: Chapman and Hall/CRC.
Lazarus, R. S., & Folkman, S. (1984). Stress, appraisal, and coping. New York: Springer.
Ghattas, B., Michel, P., & Boyer, L. (2017). Clustering nominal data using unsupervised binary decision trees: Comparisons with the state of the art methods. Pattern Recognition, 67, 177–185. https://doi.org/10.1016/j.patcog.2017.01.031. CrossRef
Lipkovich, I. A., Deberdt, W., Csernansky, J. G., Buckley, P., Peuskens, J., Kollack-Walker, S., et al. (2009). Defining “good” and “poor” outcomes in patients with schizophrenia or schizoaffective disorder: A multidimensional data-driven approach. Psychiatry Research, 170, 161–167. https://doi.org/10.1016/j.psychres.2008.09.004. CrossRefPubMed
- Clustering based on unsupervised binary trees to define subgroups of cancer patients according to symptom severity in cancer
- Springer International Publishing